All In Biotech

Drug Trial Radar · NCT00216892

Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris

Different Treatment Regimens of Calcipotriol Cream and Combination (Calcipotriol/Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris

Last checked: Nov 19, 2026Latest source record: Feb 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,032 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,032

Actual

Start

Apr 2005

Primary completion

Not stated

Study completion Dec 2005

Sponsor

Lead sponsor
LEO PharmaIndustry
Sponsor type
Industry
First posted
Sep 22, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Patients with psoriasis vulgaris of the trunk and/or limbs are randomised to treatment with: 1. 4 weeks of ointment containing calcipotriol and betamethasone dipropionate followed by 8 weeks of calcipotriol cream 2. 4 weeks of (calcipotriol plus betamethasone dipropionate) ointment followed by 8 weeks of calcipotriol cream on weekdays/ (calcipotriol plus betamethasone dipropionate) ointment on weekends 3. 4 weeks of (calcipotriol plus betamethasone dipropionate) ointment followed by 8 weeks of vehicle of calcipotriol cream The objective is to compare the efficacy and safety of the different treatment regimens

Conditions

  • Psoriasis Vulgaris

Interventions

  • Calcipotriol, (calcipotriol + betamethasone)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy of regimen (a) versus regimen (c) by % change in PASI at week 12

Locations

7 sites in 7 countries. Site status is shown where the registry gives one.

  • Universitair Ziekenhuis

    Ghent, Belgium

  • Dermatrials Research Dermatology Centre

    Hamilton, Ontario, Canada

  • Hôpital Nord, Service de Dermatologie

    Saint-Etienne, France

  • Klinikum der Goethe-Universität, Zentrum für Dermatologie und Venerologie

    Frankfurt, Germany

  • Canisius-Wilhelmina Ziekenhuis

    Nijmegen, Netherlands

  • Hospital Mutua de Terrassa Dermatology Service

    Terrassa, Spain

  • Clatterbridge Hospital, Department of Dermatology

    Merseyside, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.